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BACKGROUND & AIMS: In each hepatocyte, the spe-
cific repertoire of gene expression is influenced by its
exact location along the portocentrovenular axis of the
hepatic lobule and provides a reason for the liver
functions compartmentalization defined “metabolic
zonation.” So far, few molecular players controlling
genetic programs of periportal (PP) and perivenular
(PV) hepatocytes have been identified; the elucidation
of zonation mechanisms remains a challenge for ex-
perimental hepatology. Recently, a key role in induc-
tion and maintenance of the hepatocyte heterogeneity
has been ascribed to Wnt/b-catenin pathway. We
sought to clarify how this wide-ranging stimulus inte-
grates with hepatocyte specificity. METHODS: Reverse
transcriptase polymerase chain reaction (RT-PCR) al-
lowed the transcriptional profiling of hepatocytes de-
rived from in vitro differentiation of liver stem cells. The
GSK3b inhibitor 6-bromoindirubin-3=-oxime (BIO) was
used for b-catenin stabilization. Co-immunoprecipitations
were used to study biochemical protein interactions while
ChIP assays allowed the in vivo inspection of PV and PP
genes regulatory regions. RESULTS: We found that
spontaneous differentiation of liver stem cells gives
rise to PP hepatocytes that, after Wnt pathway activa-
tion, switch into PV hepatocytes. Next, we showed that
the Wnt downstream player LEF1 interacts with the
liver-enriched transcriptional factor HNF4a. Finally,
we unveiled that the BIO induced activation of PV
genes correlates with LEF1 binding to both its own
and HNF4a consensus, and the repression of PP genes
correlates with HNF4a displacement from its own
consensus. CONCLUSION: Our data show a direct
and hitherto unknown convergence of the canoni-
cal Wnt signaling on the HNF4a-driven transcrip-
tion providing evidences of a mechanism control-
ling liver zonated gene expression.
Most of the main metabolic functions of the liverare not uniformly distributed over the hepatic
lobule, but follow gradients of enzymatic activities
along the centrolobular/portal axis. In fact, adult
hepatocytes undergo a postdifferentiation patterning
resulting in a zonal heterogeneity of gene expression
and functions defined as “metabolic zonation.” Spe-
cific enzymatic/metabolic activities, namely, carbohy-
drate metabolism, ammonia detoxification, bile forma-
tion/transport/secretion, and drug biotransformation,
are confined to the perivenular (PV, near the cen-
trolobular vein) or periportal (PP, near the portal vein)
zones of the hepatic lobule.1 The elucidation of the
mechanisms responsible for induction and mainte-
nance of the hepatocyte heterogeneity remains a chal-
lenge in experimental hepatology.
Intriguingly, inversion of the blood flow direction
changes the enzymatic gradients and, consequently,
the zonation of some, but not all of the liver metabo-
lisms, thus revealing the influence exerted by the oxy-
gen and circulating molecules on this phenomenon.2
For the bloodstream-independent gradients, cell– cell
and cell– extracellular matrix interactions and para-
Abbreviations used in this paper: BIO, 6-bromoindirubin-3=-oxime;
CPS, carbamoyl-phosphate synthetase; ChiP, chromatin immunopre-
cipitation; Cyp1a1, cytochrome 1a1; Gls2, glutaminase 2; GLT-1, glu-
tamate transporter 1; PCR, polymerase chain reaction; PMSF, phenyl-
methylsulfonyl fluoride; PP, periportal; PV, perivenular; Rex3, reduced
in expression 3; RLSC, resident liver stem cell.
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crine signalings have been suggested as instructive
stimuli.3
Recently, concerning soluble factors, a key role of
the Wnt/b-catenin pathway has been unveiled.4 Within
the hepatic lobuli, Wnt signaling has been proposed to
originate from endothelial cells of the central vein and
to follow a stable gradient that decreases toward the
PV–PP axis.5 The Wnt pathway, triggered by a large
family of cytokines, influences several processes such
as embryonic development, planar cell polarity, cell
fate, and proliferation.6 In the absence of Wnts, b-cate-
nin is phosphorylated by a “destruction complex” con-
stituted by APC, axins, GSK3b, and CK1, then ubiqui-
tinated and proteasome degraded. On the contrary,
Wnt/b-catenin signaling, activated by binding of sol-
uble Wnts to the Frizzled receptors or by oncogenic
mutations,7,8 results in the stabilization and translo-
cation b-catenin into the nucleus where, in conjunc-
tion with members of LEF1/TCF transcription factor
family, activates the transcription of several target
genes.9 In the liver, Benhamouche et al4 observed a
mutually exclusive localization of activated b-catenin
and the negative regulator APC in the PV and in PP
hepatocytes, respectively. Moreover, these authors
demonstrated that genetic manipulation of APC ex-
pression and adenoviral delivery of the extracellular
antagonist of Wnts DKK were allowed to switch the
phenotype from PP into PV and vice versa.4
A second key element in controlling hepatic zonation
was identified in the transcriptional factor HNF4a:
Stanulovic et al10 have recently shown that this orphan
nuclear receptor regulates the zonated expression of
some genes, including Cyp7, UDP-glucuronyltransferase,
and apolipoprotein E.10 Their analysis of HNF4a knock-
out mice revealed in PV hepatocytes a maintenance of PV
genes expression and in PP hepatocytes the inhibition of
a PP gene (PEPCK) coupled to the activation of PV genes.
These observations led to the conclusion that HNF4a
exerts a dual role of activator of PP genes and inhibitor of
PV genes in PP hepatocytes.
In this work, we gathered evidence demonstrating a
direct and hitherto unknown convergence of the canon-
ical Wnt signaling pathway and HNF4a in controlling
the hepatocyte heterogeneity. We have taken advantage
of resident liver stem cells (RLSCs) that we recently iso-
lated and described as able to spontaneously differentiate
into hepatocytes and cholangiocytes and, when cultured
in appropriate conditions, into mesenchymal and neuro-
ectodermal cell lineages.11
We first observed that hepatocytes derived from in
vitro differentiation of RLSCs (RLSCdH, from RLSC-
derived hepatocytes) bear a PP transcriptional profile
that is coordinately switched into the PV phenotype by
the GSK3b inhibitor 6-bromoindirubin-3=-oxime (BIO).
Next, co-immunoprecipitation experiments demon-
strated, for the first time, an interaction between the
downstream Wnt transcriptional factor LEF1 and
HNF4a. Furthermore, we analyzed 5 HNF4a target
genes that are inversely modulated by BIO: the PV
genes glutamine synthetase (GS) and cytochrome 1a1
(Cyp1a1), the PP genes glutaminase 2 (Gls2) and H19
fetal liver mRNA (H19) and transthyretin (TTR),
whose expression was not proven to be zonal in vivo
but strongly BIO inhibited in our system. Inspection of
regulatory regions by chromatin immunoprecipitation
(ChIP) assays demonstrated that Wnt activation corre-
lates with (i) LEF1 recruitment to the HNF4a DNA
binding site and PV genes transcriptional activation
and (ii) HNF4a displacement from its consensus site
and PP genes transcriptional repression.
Our data indicate that HNF4a and Wnt signaling path-
way are active members of the same machinery that controls
the transcription of differentially zonated HNF4a-depen-
dent genes.
Methods
Cell Lines and Culture Conditions
Nontumorigenic, stable RLSC lines, obtained
from murine wild-type liver explants at various stages
of development, were previously described.11 These
cells were grown in RPMI 1640 medium, supplemented
with 10% fetal bovine serum, 50 ng/mL epidermal
growth factor, 30 ng/mL insulin-like growth factor-II
(PeproTech Inc, Rocky Hill, NJ), 10 mg/mL insulin
(Roche, Mannheim, Germany), 2 mmol/L l-glutamine,
100 mg/mL penicillin and 100 mg/mL streptomycin
(Gibco, Grand Island, NY), using collagen I (Transduc-
tion Laboratories, Lexington, UK) coated dishes (Fal-
con–BD, Franklin Lakes, NJ). For BIO treatments, nor-
mal medium was supplemented with this inhibitor
(Calbiochem, San Diego, CA) at 2.5 mmol/L final con-
centration for the indicated times.
Sequence Analysis
Regulatory sequences of murine GS, Cyp1a1,
b-actin, TTR, H19, and Gls2 were obtained from
EnsEMBL and analyzed for transcription factor bind-
ing sites with MatInspector (release 7.7; Genomatix
Software, Genomatix, Munchen, Germany), a program
using the vertebrate matrix library and optimized
thresholds.
Immunofluorescence
For indirect immunofluorescence analysis, cells
were grown on collagen I– coated dishes, fixed and
treated as described previously.12 The antibodies were
used at the following dilutions: mouse monoclonal
anti–zonula occludens 1 antibody (Zymed Laborato-
ries, South San Francisco, CA) 1/50; mouse monoclo-
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nal anti–E-cadherin (E-cad) antibody (Transduction
Laboratories; BD Biosciences Pharmingen, Palo Alto,
CA) 1/50; goat polyclonal anti-HNF4a (C-19) (Santa
Cruz Biotechnology, Santa Cruz, CA) 1/50. Secondary
antibodies (anti goat Alexa-Fluor 488 and anti-mouse
Alexa-Fluor 594, diluted 1:1,000) were from Molecular
Probes (Eugene, OR). Preparations were examined with
a Zeiss Axiophot microscope.
Immunoprecipitations and Western Blottings
Cells were lysed on ice in 50 mmol/L Tris HCl pH
8.0, 150 mmol/L NaCl, 5 mmol/L EGTA pH 8.0, 50
mmol/L NaF pH 8.0, 10% glycerol, 1.5 mmol/L MgCl2,
and 1% Triton X-100 containing freshly added protease
inhibitors cocktail tablets (Complete EDTA free; Roche,
Monza, IT). Lysates were clarified by centrifugation at 4°C;
protein concentrations were determined by Bio–Rad pro-
tein assay reagent (Bio–Rad Laboratories, Hercules, CA)
and confirmed by Coomassie staining.
For immunoprecipitations, aliquots of lysates (1 mg
of proteins) were incubated with 5 mg of anti-HNF4a
rabbit polyclonal antibody (H-171; Santa Cruz Bio-
technology) or with 5 mg of anti-LEF1 rabbit poly-
clonal antibody (Cell Signaling Technology, Beverly,
MA) or with 5 mg anti–b-catenin mouse monoclonal
antibody (BD Transduction Laboratories) overnight at
4°C. Immunocomplexes were collected on protein A-
sepharose beads (GE Healthcare, Fairfield, CT). The
beads were washed 3 times with 1% NP-40 lysis buffer
then boiled for 3 minutes in SDS sample buffer. For
Western blot analysis, proteins from cell lysates were
resolved on 10% SDS-PAGE and transferred to Pure
Nitrocellulose membrane (Bio–Rad Laboratories).
Blots were blocked in TBS-T (TBS plus 0.05% Tween-
20) containing 5% nonfat, dried milk and probed with
anti-HNF4a (C-19) goat polyclonal antibody (Santa
Cruz Biotechnology) or anti-LEF1 (C-19) goat poly-
clonal antibody (Santa Cruz Biotechnology) or anti–b-
catenin mouse monoclonal antibody (BD Transduc-
tion Laboratories). Immunocomplexes were detected
with horseradish peroxidase-conjugated species-spe-
cific secondary antiserum (Bio–Rad Laboratories) fol-
lowed by enhanced chemiluminescence reaction (Pierce
Chemical, Rockford, IL).
RNA Extraction, Reverse Transcription
Polymerase Chain Reaction (PCR), and
Real-Time Quantitative PCR
Total RNA was extracted from cultured cells
using an RNA extraction kit (NucleoSpin RNA II,
Machery, Nagel, Germany) according to the manufac-
turer’s instructions. Single-stranded cDNA was ob-
tained by reverse transcription of 1 mg of total RNA
using MMLV reverse-transcriptase (Promega, Milan,
Italy). cDNA was amplified by PCR using GoTaq en-
zyme (Promega, Milan, Italy). RT-qPCRs were per-
formed using BioRad-iQ-iCycler with SYBR-green flu-
orophore; the reactions were carried out using iQ
SYBR Green Supermix (Bio–Rad Laboratories); 40 ng
of cDNA was used as template and cycling parameters
were 95°C for 3 minutes, followed by 45 cycles of 95°C
for 30 seconds, 60°C for 1 minute, 72°C for 30 sec-
onds, and 60°C 1 0.5°C for 10 minutes. Fluorescence
intensities were analyzed using the manufacturer’s
software and relative amounts were obtained using the
22DDCt method and normalized for the b-actin. Primers
for RT-PCR and RT-qPCR and relative sequence Gen-
bank accession numbers are listed in Table 1.
Transfections and Luciferase Assay
To analyze the HNF4a promoter activity,
RLSCdH cells were co-transfected by Lipofectamine
2000 (Invitrogen, San Diego, CA) with 0.5 mg of the
pGL3 luciferase vector, containing the proximal region
of the murine HNF4a P1 promoter (2867 to 143)
fused to the firefly luciferase reporter gene, together
with a b-galactosidase expression vector. All transfec-
tions were performed in triplicate. The total amount of
transfected DNA was standardized with the corre-
sponding empty vector. Cells were either left untreated
or treated with BIO for 24 hours. Luciferase activity
was measured using the Dual Luciferase Reporter As-
say System (Promega Corporation, Madison, WI) 48
hours after transfection, according to the manufac-
turer’s instructions and normalized for b-galactosidase
activity.
ChIP Assay
ChIP assays were performed basically as previ-
ously described.13 After cross-linking with 1% formal-
dehyde, cultured cells were scraped off in ice-cold
phosphate-buffered saline plus phenylmethylsulfonyl
fluoride (PMSF), centrifuged at 1000 rpm for 5 min-
utes at 4°C and pellets resuspended in Swelling Buffer
(25 mol/L HEPES pH 7.8; 1.5 mmol/L MgCl2; 10
mmol/L KCl; 0.1% mmol/L dithiothreitol; 0.5 mmol/L
PMSF) plus a protease inhibitor mixture and incu-
bated in ice for 10 minutes. The pellets, bounced
10 –20 times up– down and centrifuged at 14,000 rpm
for 15 minutes, were resuspended in 6 mL Sonication
Buffer (50 mmol/L HEPES pH 7.9; 140 mmol/L NaCl;
1 mmol/L EDTA; 1% Triton X-100; 0.1% Na-deoxy-
cholate; 0.1% SDS; 0.5 mmol/L PMSF) supplemented
with a protease inhibitor cocktail. Cell extracts were
then sonicated to yield chromatin fragments of 100 –
300 bp. After centrifugation for 15 minutes at 14,000
rpm, supernatants were collected and precleared with
protein A-sepharose previously blocked with 1 mg/mL
of salmon sperm DNA and 1 mg/mL of bovine serum
albumin overnight with rocking at 4°C. The samples
B
A
S
IC
–
L
IV
E
R
,
P
A
N
C
R
E
A
S
,
A
N
D
B
IL
IA
R
Y
T
R
A
C
T
662 COLLETTI ET AL GASTROENTEROLOGY Vol. 137, No. 2
Table 1. Genbank Accession Numbers and Primers
Accession number Gene Oligos RT-PCR Position from TSS
NM_008261 HNF-4a For 5=-ACACGTCCCCATCTGAAG-3= 1233/1250
Rev 5=-CTTCCTTCTTCATGCCAG-3= 1485/1502
NM_009654 Albumin For 5=-GTGACAAATCCCTTCACACTC-3= 1303/1323
Rev 5=-GTCCTCAACAAAATCAGCAGC-3= 11034/11054
NM_013697 TTR For 5=-CTGGACTGGTATTTGTGTCT-3= 161/180
Rev 5=-TTGGCTGTGAAAACCACATC-3= 1360/1379
NR_001592 H19 For 5=-CTGCTGCTCTCTGGATCCTC-3= 11688/11707
Rev 5=-GTGGGTGGGTGCTATGAGTC-3= 12076/12095
NM_001033264 Gls2 For 5=-AACCCAGTGGTCTGCGCTAT-3= 1770/1789
Rev 5=-ACAATGGCACCAGCATTGAC-3= 1835/1854
NM_009052 Rex3 For 5=-AGGAGGAAGAGCGGAGCA-3= 1159/1176
Rev 5=-AAGCTGGTAACAGGGAGAGATC-3= 1727/1748
NM_001080809 Cps1 For 5=-AGCCAAGGAGCCATTGAAAA-3= 13745/13764
Rev 5=-ATTGAATGGCCCAGAGATGG-3= 13803/13822
NM_007393 b-actin For 5=-ATGGATGACGATATCGCTGCG-3= 180/1100
Rev 5=-ATCTTCATGAGGTAGTCTGTCAGG-3= 1631/1654
NM_008261 HNF4a For 5=-ATCTTCTTTGATCCAGATGCCA-3= 1994/11015
Rev 5=-GTTGATGTAATCCTCCAGGC-3= 11070/11089
NM_013697 TTR For 5=-GTCCTCTGATGGTCAAAGTC-3= 1115/1134
Rev 5=-CTCCTTCTACAAACTTCTCATCTG-3= 1265/1288
NM_001033264 Gls2 For 5=-AACCCAGTGGTCTGCGCTAT-3= 1770/1789
Rev 5=-ACAATGGCACCAGCATTGAC-3= 1835/1854
NM_009052 Rex3 For 5=-AGGAGGAAGAGCGGAGCA-3= 1159/1176
Rev 5=-AAGCTGGTAACAGGGAGAGATC-3= 1727/1748
NM_007482 Arginase For 5=-AAGCTGGTCTGCCTGGAAAAA-3= 1200/1219
Rev 5=-CTGGTTGTCAGGGGAGTGTT-3= 1490/1509
NR_001592 H19 For 5=-CTGCTGCTCTCTGGATCCTC-3= 11688/11707
Rev 5=-GTGGGTGGGTGCTATGAGTC-3= 12076/12095
NM_009992 CyP1A1 For 5=-CCGGCATTCATCCTTCGT-3= 11320/11337
Rev 5=-GCCATTCAGACTTGTATCTCTTGT-3= 11363/11386
NM_008131 GS For 5=-CGGCCACCGCTCTGAA-3= 1102/1117
Rev 5=-ACATTTGCTTGATGCCTTTGTTC-3= 1155/1177
NM_001077514 GLT-1 For 5=-ATGTCCACGACCATCATTGC-3= 1373/1392
Rev 5=-ACCTCGTCGTTCTTCTTCCC-3= 1466/1485
NM_009803 CAR For 5=-GCTGCCTAAGGGAAACAGGA-3= 1187/1206
Rev 5=-AGCAAACGGACAGATGGGAC-3= 1371/1390
NM_016978 OAT For 5=-GCCCTTTCTGGCGGTTTATAC-3= 11017/11037
Rev 5=-TGGTTTAATGGTCAGCATTATCTCA-3= 11064/11088
NM_007393 b-actin For 5=-ACCACACCTTCTACAATGAG-3= 1339/1358
Rev 5=-AGGTCTCAAACATGATCTGG-3= 1439/1458
ENSMUSG00000032315 CyP1A1 For 5=-CTATGAACTGCCAGAGCACA-3= 136494/136513
Rev 5=-TACTGGACCTCACTGAGACT-3=
(Consensus HNF4a)
136587/136606
CyP1A1 For 5=-CTGGCTGCAGCATTGGATGA-3= 136344/136363
Rev 5=-TGTGCTCTGGCAGTTCATAG-3=
(Consensus LEF1)
136494/136513
CyP1A1 For 5=-CCACGCCAACATCTACCTCA-3= 136473/136492
Rev 5=-AGTCCCTTCATGTGCTCTGG- 3=
(Interconsensus region)
136504/136520
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were centrifuged and the supernatants (precleared sol-
uble chromatin) divided into 1-mL aliquots in Eppen-
dorf tubes for IP. From each supernatant, 1/20th of
the amount used for IP were utilized as input sample.
Immunoprecipitation was performed adding 5 mg of
anti-HNF4a rabbit polyclonal antibody (H-171; Santa
Cruz Biotechnology) or anti-LEF1 rabbit polyclonal
antibody (Cell Signaling Technology), or without spe-
cific antibody as control, rotating samples for 2 hours
at 4°C, adding protein A-sepharose beads to collect the
antibody/protein/DNA complexes and finally incubat-
ing overnight at 4°C by constant rotation. The beads
were centrifuged at 6,000 rpm for 3 minutes and
washed twice with 1 mL of sonication buffer, twice
with 1 mL of wash buffer A (50 nmol/L HEPES pH 7.9;
500 mmol/L NaCl; 1 mmol/L EDTA; 1% Triton X-100;
0.1% Na-deoxycholate; 0.1% SDS; 0.5 mmol/L PMSF)
supplemented with protease inhibitor cocktail, twice
with 1 mL of wash buffer B (20 mmol/L Tris pH 8.0; 1
mmol/L EDTA; 250 mmol/L LiCl; 0.5% NP-40; 0.5%
Na-deoxycholate; 0.5 mmol/L PMSF, protease inhibi-
tors), and twice with 1 mL of Tris-EDTA buffer. Pre-
cipitates were then extracted twice with 200 mL of
elution buffer (50 mmol/L NaHCO3; 1% SDS; 1
nmol/L EDTA; 50 mmol/L Tris pH 8.0) incubating at
65°C for 10 minutes and centrifuging at 14,000 rpm
for 1 minute. Both elutions were combined, supple-
mented with 21 mL of NaCl 4 mol/L, and incubated
overnight at 65°C to reverse formaldehyde cross-link-
ing. Samples, previously incubated at 37°C for 1 hour
with 10 mg of RNAse, were then treated with 20 mg of
proteinase K for 1 hour at 51°C plus 4 mL of EDTA 0.5
mol/L. Chromatin was extracted with phenol/chloro-
form/isoamyl alcohol, precipitated at 220°C over-
night with ethanol in the presence of tRNA as carrier,
and finally resuspended in 100 mL 10 mmol/L Tris (pH
7.5). For PCR amplification, 1 mL of each ChIP reac-
tion and 1 mL of a 1:20 dilution of starting chromatin
Table 1. Continued
Accession number Gene Oligos RT-PCR Position from TSS
ENSMUSG00000026473 GS For 5=-GCAAGCCAGTTAAGGAGGGA-3= 22774/22755
Rev 5=-CTCCCGTAGCCCTCGAATAG-3=
(Consensus HNF4a)
22483/22463
GS For 5=-ATCGTGTTCACTGCTCCCAT-3= 22351/22331
Rev 5=-GGTGTAGACCAGCAACAA-3=
(Consensus LEF1)
22159/22142
GS For 5=-GCAAGCCAGTTAAGGAGGGA-3= 22774/22574
Rev 5=-GGTGTAGACTCAGCAACAA-3=
(Interconsensus region)
22160/22142
ENSMUSG00000000031 H19 For 5=-CGTGACGACTCACCCAGAAAA-3= 2580/2560
Rev 5=-CGGAGTATGAACAGCCTACG-3=
(Consensus HNF4a)
2456/2437
H19 For 5=-CTCTCCACGCTGTGCAGATT-3= 22252/22233
Rev 5=-CCGCCTATAACCGATTCTGT-3=
(Consensus LEF1)
22020/22001
ENSMUSG00000061808 TTR For 5=-CAACACTGTCAGACTCAAAG-3= 2301/2282
Rev 5=-CTGCCAAGCTGACTCCAAAC-3=
(Consensus HNF4a)
280/262
TTR For 5=-GGTCATCAGTAGTTTTCCAT-3= 21821/21802
Rev 5=-TAGTTCTGACCAACTACCAA-3=
(Consensus LEF1)
21651/21632
ENSMUSG00000044005 Gls2 For 5=-CAGATCTCATTACAGATGAT-3= 22560/22541
Rev 5=-GACAGTGTACTTACATACATT-3=
(Consensus HNF4a)
22433/22413
Gls2 For 5=-CTGAGTACTACGGCAACAAG-3= 2988/2969
Rev 5=-Rev 5=-TCATTGCTAGGCGTCATGGA-3=
(Consensus LEF1)
2680/2661
ENSMUSG00000029580 b-actin For 5=TTACGCCTAGCGTGTAGACTCT-3= 1219/1241
Rev 5=AATACTGTGTACTCTCAAGATGGA-3= 1378/1402
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DNA (Input) were used as templates and 35 PCR cycles
were performed by using the primers listed in Table 1.
Results
Hepatocytes Derived From RLSCs Show a PP
Phenotype
We first analyzed the RLSC spontaneous differ-
entiation program. Within a few weeks of culture,
these cells, characterized by a flattened morphology
and growing in a scattered fashion, spontaneously
acquired a cuboidal and tightly packed hepatocyte-like
morphology. These differentiated cells, here indicated
as RLSC-derived hepatocytes (RLSCdH), expressed the
polarity markers zonula occludens 1 and E-cad as well
as the liver enriched transcriptional factor HNF4a
(Figure 1A).
Next, we analyzed whether RLSCdH recapitulate one
of the mutually exclusive PP or PV molecular phenotypes.
Notably, RT-PCR analysis demonstrated that RLSCdH
express, together with albumin and TTR, several PP mark-
ers, such as H1914, Gls24, reduced in expression 3 (Rex314)
and carbamoyl-phosphate synthetase 1 (CPS4), but not the
PV markers Cyp1a1,14 GS14, glutamate transporter 1 (GLT-
14), constitutive androstane receptor (CAR14), and ornithine
amino transferase (OAT4) (Figures 1B and 2A).
Thus, the in vitro spontaneous differentiation of RLSC
into RLSCdH results in the acquisition of a PP pheno-
type.
Inhibition of GSK3b Activity in RLSCdH
Induces a Reversible Switch From PP to PV
Phenotype
Although animal models allowed the demonstra-
tion that Wnt centroportal gradient correlates with PV
hepatocyte markers expression, the study of conversion
of distal PP hepatocytes into PV as well as the negative
influence of b-catenin–mediated canonical Wnt signaling
on PP phenotype cannot be easily assessed in vivo.
Figure 1. RLSC spontaneously
differentiate in PP hepatocytes.
(A) Phase-contrast micrographs
and immunofluorescence analy-
sis for the polarization markers
E-cad and zonula occludens 1
and for HNF4a of RLSC and
their counterpart differentiated
into hepatocytes (RLSCdH). (B)
Comparative RT-PCR analysis
between RLSCs and RLSCdH
cell lines for the indicated liver
specific transcriptional factors
and hepatic products; b-actin
amplification was used for tem-
plate normalization.
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We analyzed the RLSCdH transcriptional PP and PV
profiles upon treatment with the indirubin BIO, a widely
employed pharmacologic inhibitor of GSK-3b function
that mimics Wnt canonical signaling activation, inducing
efficient b-catenin stabilization.15,16
Interestingly, RLSCdH, which are responsive to BIO
as assessed by a TopFlash luciferase reporter assay
(data not shown), modified their PP phenotype in
response to the GSK3b inhibition. Figure 2A shows the
results of a qRT-PCR analysis performed on cells
treated with BIO for 72 hours. In this condition, PP
markers such as Gls2, Rex3, arginase and H19, as well
as TTR, were found to be down-regulated and the PV
markers Cyp1a1, GS, GLT-1, CAR and OAT resulted
significantly induced. Thus, pharmacologic Wnt path-
way activation (i) interferes with PP and (ii) induces PV
gene expression. Notably, the BIO effect was reversible,
as demonstrated by semiquantitative RT-PCR analysis
of BIO-treated cells at different time points after with-
drawal of this inhibitor; the BIO-inhibited TTR expres-
sion was progressively restored, whereas the BIO-in-
duced Cyp1a1 expression was repressed in a few hours
(Figure 2B).
HNF4a Interacts With the Wnt Canonical
Signaling Pathway Effector LEF1
A recent study by Stanulovic et al10 revealed that
HNF4a deficiency causes expression of PV genes in PP
hepatocytes. Because 7 out of 10 genes we proved to be
BIO-responsive in RLSCdH have been described as
HNF4a-dependent (ie, TTR, H19, Arg119; GS, OAT10;
Cyp1a1,17 CAR), we asked whether Wnt-mediated canon-
ical signaling pathway converges on HNF4a transcrip-
tional activity in controlling hepatic zonation.
First, we considered the possibility that GSK3b inacti-
vation modulates HNF4a isoform-specific mRNA steady-
state levels. Although we found that both HNF4a1 and
HNF4a7 are expressed in RLSCdH (data not shown),
both qRT-PCR analysis of endogenous HNF4a (Figure
3A) and luciferase assay using an HNF4a promoter con-
struct (Figure 3B) demonstrated that HNF4a transcrip-
tion is not affected by BIO treatment. Furthermore,
Figure 2. Inhibition of GSK3b
activity in RLSCdH changes the
phenotype from PP to PV in a
reversible manner. (A) qRT-PCR
analysis for the indicated genes
on RLSCdH treated or not with
BIO for 72 hours. The real-time
PCR results were calculated by
the DDCT Method. (B) Semi-
quantitative RT-PCR analysis for
TTR and Cyp1a1 mRNAs from
RLSCdH untreated (2), treated
with BIO for 72 hours and
treated with BIO for 72 hours
and then cultured for the indi-
cated times in absence of the in-
hibitor (Reversion, -BIO); b-actin
and the nonresponsive albumin
amplifications were used for
template normalization.
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HNF4a was neither influenced at protein level as revealed
by Western blot analysis (Figure 3C). Altogether, these
data exclude that HNF4a is a Wnt target gene.
Next, we asked whether HNF4a, LEF1, and b-catenin
directly cooperate in their functions. To this aim, we
performed experiments of co-immunoprecipitations by
using total protein lysates from RLSCdH. We found that
endogenous proteins HNF4a and LEF1 can be reciprocally
immunoabsorbed from common complexes, whereas an
interaction between HNF4a and b-catenin was not detected
(Figure 3D). These results provide the first intriguing
evidence of a biochemical interaction between HNF4a
and the Wnt canonical pathway effector LEF1, thus sup-
porting the hypothesis of a convergence between these 2
molecular pathways in liver zonation.
Inhibition of GSK3b Activity Modifies
HNF4a and LEF1 Recruitment on
“Zonated” Genes
The biochemical evidence of the HNF4a/LEF1
interaction prompted us to investigate functional coop-
eration of these transcriptional factors in the chromatin
context by means of ChIP assays. We focused our analysis
on GS and Cyp1a1, prototypes of PV genes, on Gls2 and
H19, prototypes of PP genes, as well as on TTR; these
genes are in fact all modulated by BIO in RLSCdH and
described to be HNF4a targets.10,17–19
Figure 4 illustrates the results of ChIP assays per-
formed on the PV genes GS and Cyp1a1 regulatory re-
gions, using either anti-LEF1 (Figure 4A and C) or anti-
HNF4a (Figure 4B and D) antibodies. Interestingly, we
found that BIO treatment, which activates transcription
of these genes, induces LEF1 recruitment not only on its
own binding site but also on HNF4a site; in particular,
on the Cyp1a1 gene, both transcription factors were
found on HNF4a consensus whereas for the GS gene,
their binding seemed to be mutually exclusive. The PCR
analysis (Figure 4C) of amplicons spanning LEF1 and
HNF4 interconsensus regions in the GS gene ruled out
the possibility that ChIP with LEF1 antibody pulled
down DNA fragments with both LEF1 and HNF4 sites.
For Cyp1a1, the results obtained are less interpretable
(Figure 4A).
On the other hand, regarding TTR and the PP genes
Gls2 and H19, the BIO-induced transcriptional repres-
Figure 3. HNF4a is not a Wnt target gene, but interacts with LEF1. qRT-PCR analysis of HNF4a transcripts from RLSCdH treated or not with BIO
for 72 hours. The real-time PCR results were calculated by DDCT Method. (A) HNF4a promoter Luciferase activity. RLSCdH cotransfected with the
reporter construct carrying the proximal 2867/143 region of the HNF4a P1 promoter or with the pGL3basic vector (Ctrl), were treated or not with
BIO for 72 hours. Data represent the mean values 6 SD of 3 independent experiments. (B) Western blot analysis of HNF4a expression in RLSCdH
treated or not with BIO for 72 hours. Protein amount was normalized by immunoblotting for tubulin. (C) Co-immunoprecipitation analysis of HNF4a,
LEF1, and b-catenin. Lysates from RLSCdH cells treated or not with BIO for 72 hours, were subjected to immunoprecipitation with anti-HNF4a, or
anti-LEF1, or anti–b-catenin antibodies and protein A sepharose. After SDS/PAGE, blots were probed with the indicated antibodies (see Methods).
Aliquots (7%) of the total cell extracts were used for Western blot analysis as a control for expression level.
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sion correlates with both LEF1 binding and HNF4a
displacement from their own consensus sites. In partic-
ular, LEF1 binds its own consensus site exclusively upon
BIO treatment (Figure 5A, C, and E), whereas HNF4a,
which is constitutively bound to DNA, is displaced by
GSK3b inhibition (Figure 5B, D, and F). Thus, Gls2, H19,
and TTR transcriptional activity correlates directly to the
HNF4a binding to its own binding site, whereas LEF1
seems not to be a positive regulator. Figure 6 summarizes
all described results.
Altogether these data provide new molecular basis for
the Wnt- and HNF4a-mediated transcriptional activa-
tion and repression of zone-specific expressed genes.
Discussion
The specific gene expression repertoire of single
hepatocyte, is correlated with its anatomic location in the
hepatic lobule and, therefore, with the different demand
of liver functions. How the liver-specific gene expression
is zonally controlled by the microenvironmental signals
is a relevant issue in experimental hepatology.
In vivo evidence arising from genetic manipulation
and from liver tumors, although indicating the in-
volvement of specific morphogenetic factors (ie, oxy-
gen, Wnts, and growth factors) and cellular effectors
(ie, b-catenin and Ras), suggest that hepatocytes zona-
tion is a complex phenomenon and that it cannot be re-
conducted to a single specific effector.
The main finding of this work was to unveil that LEF1
interacts with HNF4a and, upon b-catenin stabilization,
may be also recruited on HNF4 DNA binding sites, thus
providing first evidence that may explain how the Wnt
signaling pathway influences the zonal control of liver
gene expression.
In the attempt to contribute to the clarification of
molecular mechanisms controlling zonation, we took
advantage of a cellular model that we recently devel-
oped,11 the RLSC, which spontaneously differentiates
into PP hepatocytes (RLSCdH from RLSC-derived hepa-
tocytes). This is a first, provocative result and suggests
that PP hepatocytes could represent the initial differen-
tiation step of liver precursors. In line with this possibil-
ity are the in vivo observations that (i) the stem cells
compartment is located around portal tracts and (ii)
during liver growth hepatocytes increase the distance
from the portal tract toward central vein, although the
4™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™
Figure 4. Inhibition of GSK3b activity influences the binding of HNF4a
and LEF1 on PV GS and Cyp1a1 genes. ChIP analysis with anti-LEF1 (A
and C) or anti-HNF4a (B and D) antibodies of chromatin derived from
RLSCdH treated or not with BIO. As controls, ChIPs were also per-
formed without antibody or with unrelated IgG. b-Actin gene sequence
was amplified as control unrelated DNA. A 1:20 dilution of starting
chromatin DNA was used as PCR template for input normalization. The
consensus sites for the transcriptional factors LEF1 and HNF4a in the
regulatory region of GS and Cyp1a1 are depicted as black boxes and
their double-strand sequences and positions relative to the transcrip-
tion start point (11) are indicated. PCR primers are represented as
dotted arrows and listed in Table 1.
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proliferation gradient decreases.20,21 A second, relevant
observation came from the analysis of RLSCdH differen-
tiation pattern after treatment with the GSK3b-inhibitor
BIO, which mimics Wnt pathway activation. RLSCdH
respond to this chemical with modification of their tran-
scriptional profile, inducing all PV and repressing all PP
genes analyzed, coherently recalling what unveiled for PV
hepatocytes in vivo. Moreover, we conclude that both
regulatory processes, induction and repression of subsets
of genes, can be ascribed to the Wnt pathway activity and
thus, at least for two of them (Cyp1a1 and TTR), in a
notably reversible fashion.
A similar, dual role of activator and repressor of zonated
genes has been proposed also for HNF4a on the basis of the
results obtained with knockout mice. In fact, its genetic
depletion resulted in both the activation of PV genes (ie, GS
and OAT) and the impairment of the PP gene PEPCK in PP
hepatocytes.10 On the other hand, the quite homogenous
expression of HNF4a throughout the hepatic lobule22 sug-
gests the existence of further elements controlling zonation.
Figure 5. Inhibition of GSK3b
activity in RLSCdH influences
the recruitment of HNF4a on PP
Gls2, H19 genes, and on TTR
gene. ChIP analysis with anti-
HNF4a (A, C, E) or anti-LEF1 (B,
D, F) antibodies of chromatin de-
rived from RLSCdH treated or
not with BIO. As controls, ChIPs
were also performed with no an-
tibody or with unrelated IgG.
b-Actin gene sequence was am-
plified as unrelated DNA control.
A 1:20 dilution of starting chro-
matin DNA was used as PCR
template for input normalization.
The consensus sites for the tran-
scriptional factors HNF4a and
LEF1in the regulatory regions of
Gls2, H19, and TTR are de-
picted as black boxes and their
double-strand sequences and
positions relative to the tran-
scriptional start point (11) are in-
dicated. PCR primers are repre-
sented as dotted arrows and
listed in Table 1.
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Our data indicate Wnt as a regulative element of the differ-
ential HNF4a transcriptional activity.
In this work, we sought to explore whether Wnt-medi-
ated canonical signaling converges on HNF4a transcrip-
tional activity. Ruling out the possibility that HNF4a is a
Wnt target gene, we surprisingly observed, by means of
reciprocal coimmunoprecipitation experiment, a bio-
chemical interaction between the endogenous down-
stream Wnt transcriptional factor LEF1 and HNF4a.
This unexpected biochemical evidence does not provide
per se any indication of its occurrence in the context of
chromatin or of its functional significance in the process
of liver zonation. Therefore, we performed ChIP assays
on HNF4a-dependent regulatory regions of “differen-
tially zonated” genes. We focused our analysis on GS and
Cyp1a1, prototypes of PV genes, and on Gls2 and H19,
prototypes of PP genes as well as on the TTR gene, all
modulated by BIO in RLSCdH and described to be
HNF4a targets.10,17–19 The inspection of both HNF4a
and LEF1 consensus binding sites of these genes gave us
interesting evidences for proposing the schematic model
depicted in Figure 6.
Concerning GS regulatory region, we found that
HNF4a binds its own consensus site only when the gene
is not transcribed; on the contrary, transcription corre-
lates with LEF1 recruitment on its own binding site and,
surprisingly, on HNF4a cis-element. For Cyp1a1, we
found that HNF4a binds its own cis-element irrespective
of transcriptional activity; gene expression is instead in-
duced when LEF1 is recruited to its own consensus. Also
for this gene we gathered evidence suggesting LEF1 bind-
ing to HNF4a consensus site, thus paralleling the obser-
vation made for GS. However, the closed proximity of the
2 consensus sites on this promoter may result in ChIP
amplicons covering both consensus sites. Even if such
amplicons are not found in the reciprocal HNF4a anti-
body ChIP assay, suggesting a chromatin fragmentation
appropriate for our analysis, we prefer to leave open this
specific matter.
Our data, although obtained analyzing only 2 exem-
plificative PV genes, suggest a repressive role for HNF4a;
this seems to be in line with the previous report of
Stanulovic et al,10 where HNF4a was found to be neces-
sary for GS PP suppression, through the recruitment of
HDAC on its regulatory regions.
The unexpected finding of a b-catenin–induced LEF1
recruitment, not only on its consensus site but also on
that of HNF4a, suggests that the transcriptional acti-
vation of PV genes may require an LEF1-mediated
inhibition of HNF4a repressive activity. On the other
hand, for the PP genes Gls2 and H19, and for TTR, we
found that during their expression HNF4a is bound to
its own DNA binding sites, whereas upon activation of
Wnt/b-catenin pathway (ie, when transcription is re-
Figure 6. Schematic depiction
of LEF1 and HNF4a consensus
sites occupancy in RLSCdH in
relation with BIO treatment.
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pressed) HNF4a is displaced, concomitant with the
recruitment of LEF1 only to its own consensus sites.
Although, for these genes, HNF4a clearly seems to
explicate a positive role in transcription, further stud-
ies are necessary to address the BIO-mediated mecha-
nism(s) of its displacement.
Overall, we provided new evidence of cooperation
among a microenvironmental signal and a tissue-spe-
cific factor in maintaining the heterogeneity of gene
expression within the same histotype.
We propose that both PP and PV hepatocytes ac-
tively respond to influences arising from the same
effectors, namely HNF4a and Wnt signaling, resulting,
within the same cell, in negative and positive transcrip-
tional activity independence on different promoter
structures.
This is in line with other, previously identified, tis-
sue-specific mechanisms conferring specificity to Wnt
signaling. For example, myoblast differentiation re-
quires the cross-talk between Wnt/LEF1 and BMP-2,
whereas the physical interaction between Alx-4 and
LEF1 gives rise to Wnt pathway mesenchymal-specific
activities.23,24 Further experiments shall dissect molec-
ular machinery that, most likely through epigenetic
modification, mediates the activation and repression
of zonated genes in the hepatocyte. Moreover, we be-
lieve it would be desirable to extend our observations
to hepatocytes isolated from specific zones of liver
lobules. Indeed, we believe that certain data indicate
that further elements control in vivo zonation, for
example (i) the TTR gene, found strongly BIO-inhib-
ited in our system, is not repressed in PV hepatocytes
in vivo; and (ii) other genes whose zonality depends on
Wnt dynamically respond also to metabolic or hor-
monal changes (ie, CPS, OAT, and CyPs).4
Finally, Wnt activation has also been related to pro-
liferation of hepatic precursors cells (ie, oval cells25)
that are believed to be located in the PP region where
Wnt is low. This suggests that in conditions favoring
the precursor compartment expansion Wnt gradient
and in turn hepatic zonation may be perturbed as
intriguingly it occurs during posthepatectomy regen-
eration.26
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